Literature DB >> 26546503

Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice.

Yessenia Valverde1, Barbara Benson1, Mihir Gupta2, Kalpna Gupta3.   

Abstract

Entities:  

Keywords:  CoQ10; astrocyte; curcumin; glial; pain; sickle cell anemia

Mesh：

Substances：

Year:  2015        PMID： 26546503      PMCID： PMC4938337          DOI： 10.3324/haematol.2015.137489

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  Astrocytic calcium signaling: the information currency coupling neuronal activity to the cerebral microcirculation.

Authors:  Stephen V Straub; Mark T Nelson
Journal:  Trends Cardiovasc Med       Date:  2007-08       Impact factor: 6.677

2.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

3.  Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.

Authors:  David M Cain; Derek Vang; Donald A Simone; Robert P Hebbel; Kalpna Gupta
Journal:  Br J Haematol       Date:  2011-12-15       Impact factor: 6.998

4.  Mast cell activation contributes to sickle cell pathobiology and pain in mice.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Mihir Gupta; Kathryn Luk; Marna E Ericson; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

5.  Hematological Parameters and RBC TBARS Level of Q 10 Supplemented Tribal Sickle Cell Patients: A Hospital Based Study.

Authors:  A S Thakur; G P Littaru; S Moesgaard; C Dan Sindberg; Y Khan; C M Singh
Journal:  Indian J Clin Biochem       Date:  2012-11-20

6.  Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.

Authors:  L A Michaels; K Ohene-Frempong; H Zhao; S D Douglas
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

7.  Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease.

Authors:  Giuseppe Cataldo; Sugandha Rajput; Kalpna Gupta; Donald A Simone
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

8.  Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis.

Authors:  Jun-Jie Chen; Lin Dai; Lin-Xia Zhao; Xiang Zhu; Su Cao; Yong-Jing Gao
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

Review 9.  Morphine for the treatment of pain in sickle cell disease.

Authors:  Mihir Gupta; Lilian Msambichaka; Samir K Ballas; Kalpna Gupta
Journal:  ScientificWorldJournal       Date:  2015-01-12

10.  Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats.

Authors:  Farid A Badria; Ahmed S Ibrahim; Adel F Badria; Ahmed A Elmarakby
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240
View more
  21 in total

Review 1.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

2.  Genetic inactivation of calpain-1 attenuates pain sensitivity in a humanized mouse model of sickle cell disease.

Authors:  Jennifer O Nwankwo; Jianxun Lei; Jian Xu; Alicia Rivera; Kalpna Gupta; Athar H Chishti
Journal:  Haematologica       Date:  2016-07-14       Impact factor: 9.941

Review 3.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

Review 4.  Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.

Authors:  Varun Sagi; Donovan A Argueta; Stacy Kiven; Kalpna Gupta
Journal:  Complement Ther Med       Date:  2020-05-11       Impact factor: 2.446

5.  Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.

Authors:  Claudia R Morris; Lou Ann S Brown; Michael Reynolds; Carlton D Dampier; Peter A Lane; Amanda Watt; Polly Kumari; Frank Harris; Shaminy Manoranjithan; Reshika D Mendis; Janet Figueroa; Sruti Shiva
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

Review 6.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.

Authors:  Amanda M Brandow; Nancy J Wandersee; Mahua Dasgupta; Raymond G Hoffmann; Cheryl A Hillery; Cheryl L Stucky; Julie A Panepinto
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

8.  Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches.

Authors:  Steven D Douglas
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

9.  Redox Signaling in Sickle Cell Disease.

Authors:  Deirdre Nolfi-Donegan; Tirthadipa Pradhan-Sundd; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Curr Opin Physiol       Date:  2019-05-02

Review 10.  Therapeutic strategies for sickle cell disease: towards a multi-agent approach.

Authors:  Marilyn J Telen; Punam Malik; Gregory M Vercellotti
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.